RBC Capital on Boston Scientific (BSX): 'Results Point to Positive Uptake'
Tweet Send to a Friend
RBC Capital analyst Shagun Singh reiterated an Outperform rating and $115.00 price target on Boston Scientific (NYSE: BSX).The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
